Pulsed laser ablation synthesis of thiol-functionalized W/Fe nanoparticles in liquid for MRI and CT imaging
Source abstract
Abstract
Novel Thiol-functionalized tungsten iron oxide nanoparticles with potential applications as contrast agents in medical imaging have been obtained using scanning pulsed ablation in liquid. First, bulk ceramic targets of an orthorhombic (Pbcn) iron (III) tungstate phase type γ-Fe2WO6 with a tri-a-PbO2 structure were prepared using a reaction-sintering method. Then, colloidal dispersions of nanoparticles were produced directly in both distilled water and ethanol by irradiating bulk γ-Fe2WO6 targets with high-power infrared nanosecond laser pulses. In addition, ex situ functionalization processes using glutathione or cysteamine as capping agents were applied, to enhance biocompatibility and colloidal stability at physiological pH values. A battery of techniques was used to characterize the γ-Fe2WO6 targets, the as-synthesized and the functionalized colloidal dispersions of W/Fe nanoparticles, including their composition, structure, magnetic properties, X-ray attenuation potential, biocompatibility and colloidal properties. The results indicate the successful formation of amorphous W/Fe nanoparticles using both distilled water or ethanol as the ablation medium, although only those synthesized in ethanol display a dominant ferromagnetic behavior, making them suitable for use as contrast agents in MRI. Moreover, nanoparticle colloidal dispersions synthesized in ethanol exhibit high X-ray attenuation. The linkage mechanism of functionalization was extensively studied to obtain information for subsequent bioconjugation. The formation of NPs with higher stability and proper functionalization occurs when cysteamine was used as a capping agent, although biocompatibility is better when using glutathione. Finally, functionalized W/Fe nanoparticles demonstrated good magnetic resonance imaging and X-ray computerized tomography imaging abilities, suggesting promising potential as dual-contrast agents.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Laser-Ablation Synthesis of Nanoparticles · Laser Material Processing Techniques · Geomagnetism and Paleomagnetism Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (77)
Show source-provided references
1. Nanoparticle size effects in biomedical applications10.1021/acsanm.1c00987 ↗
2. Surface-bioengineered gold nanoparticles for biomedical applications10.2174/0929867325666180117111404 ↗
3. Biomedical applications of organosilica nanoparticles toward theranostics10.1515/ntrev-2012-0005 ↗
4. Potential biomedical applications of metallic NANOBIOMATERIALS: a review
5. Magnetic hyperthermia in cancer therapy, mechanisms, and recent advances: a review10.1177/08853282241244707 ↗
6. The application of nanoparticles in diagnosis and theranostics of gastric cancer10.1016/j.canlet.2016.10.032 ↗
7. Subcellular imaging and diagnosis of cancer using engineered nanoparticles10.2174/1381612827666210525154131 ↗
8. Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment10.1007/s40005-019-00459-7 ↗
9. Recent advances in the development of noble metal NPs for cancer therapy
10. Iqbal · 2019
11. Advances in oral peptide drug nanoparticles for diabetes mellitus treatment
12. Medical imaging of tissue engineering and regenerative medicine constructs10.1039/D0BM00705F ↗
13. Modified natural nanoparticles as contrast agents for medical imaging10.1016/j.addr.2009.11.005 ↗
14. Magnetite nanoparticles for medical MR imaging10.1016/S1369-7021(11)70163-8 ↗
15. Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in X-ray computed tomography of live mice10.1021/nl101019s ↗
16. Bimodal Nd-Doped LuVO4 nanoprobes functionalized with polyacrilic acid for X-Ray computed tomography and NIR luminescent imaging10.3390/nano10010149 ↗
17. Porous noble metal-based nanomaterials in biomedical applications10.1002/anbr.202300078 ↗
18. Evaluation of average glandular dose and investigation of the relationship with compressed breast thickness in dual energy contrast enhanced digital mammography and digital breast tomosynthesis10.1016/j.ejrad.2020.108912 ↗
19. Magnetic resonance imaging: the evolution of breast imaging10.1016/j.breast.2013.07.014 ↗
20. Recent advances in the use of magnetic nanoparticles in bio-imaging applications10.1166/nnl.2019.2969 ↗
21. Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs10.1166/jbn.2011.1324 ↗
22. Dual nano-sized contrast agents in PET/MRI: a systematic review10.1002/cmmi.1719 ↗
23. Radiolabeled PET/MRI nanoparticles for tumor imaging
24. Cosubstitution of lanthanides (Gd3+/Dy3+/Yb3+) in β-Ca3(PO4)2 for upconversion luminescence, CT/MRI multimodal imaging10.1021/acsbiomaterials.7b00742 ↗
25. Biocompatible magnetite/Gold nanohybrid contrast agents via green chemistry for MRI and CT bioimaging10.1021/am201311c ↗
26. Heavy metal-based nanoparticles as high-performance X-ray computed tomography contrast agents10.3390/ph16101463 ↗
27. Synthesis, characterization, and biological properties of iron oxide nanoparticles synthesized from Apis Mellifera honey10.3390/molecules28186504 ↗
28. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging10.1021/ja1035013 ↗
29. Feasibility study of Fe3O4/TaOx nanoparticles as a radiosensitizer for proton therapy10.1088/1361-6560/aac27b ↗
30. A dual-mode T1 MRI/CT contrast agent of Gd2O3/Au@MSNs for tumor imaging with high performance10.1016/j.mtla.2022.101494 ↗
31. Polypyrrole-based double rare earth hybrid nanoparticles for multimodal imaging and photothermal therapy10.1039/C9TB02254F ↗
32. Ex situ and in situ functionalized Yb/Fe nanoparticles obtained by scanning pulsed laser ablation in liquids: a route to obtain biofunctionalized multiplatform contrast agents for MRI and CT imaging10.1016/j.powtec.2023.118733 ↗
33. Scanning pulsed laser ablation in liquids: an alternative route to obtaining biocompatible YbFe nanoparticles as multiplatform contrast agents for combined MRI and CT imaging10.1016/j.ceramint.2022.11.099 ↗
34. Solvothermal synthesis and characterization of ytterbium/iron mixed oxide nanoparticles with potential functionalities for applications as multiplatform contrast agent in medical image techniques10.1016/j.ceramint.2022.06.194 ↗
35. Polypyrrole-encapsulated iron tungstate nanocomposites: a versatile platform for multimodal tumor imaging and photothermal therapy10.1039/C6NR03336A ↗
36. Hybrid FeWO4-Hyaluronic acid nanoparticles as a targeted nanotheranostic agent for multimodal imaging-guided tumor photothermal therapy10.2147/IJN.S432533 ↗
37. Electronic structure and magnetic properties of FeWO4 nanocrystals synthesized by the microwave-hydrothermal method10.1016/j.matchar.2012.08.006 ↗
38. A review on synthesis and applications of tungsten oxide nanoparticles and their polymer composites10.1142/S0219581X22300012 ↗
39. Chitosan coated tungsten trioxide nanoparticles as a contrast agent for X-ray computed tomography10.1016/j.ijbiomac.2017.01.138 ↗
40. Femtosecond laser generation of bimetallic oxide nanoparticles with potential X-ray absorbing and magnetic functionalities for medical imaging applications10.1016/j.ceramint.2021.07.103 ↗
41. Laser-assisted synthesis of colloidal FeWxOy and Fe/FexOy nanoparticles in water and ethanol10.1002/cphc.201701214 ↗
42. Study of the physicochemical surface alterations and incubation phenomena induced on iron targets by nanosecond pulsed laser ablation in liquids: effect on productivity and characteristics of the synthesized nanoscale zero-valent iron (nZVI) particles10.1016/j.apsusc.2020.145438 ↗
43. Pursuit of optimal synthetic conditions for obtaining colloidal zero-valent iron nanoparticles by scanning pulsed laser ablation in liquids10.1016/j.jiec.2019.09.024 ↗
44. Nanomaterials via laser ablation/irradiation in liquid: a review10.1002/adfm.201102295 ↗
45. Laser synthesis and processing of colloids: fundamentals and applications10.1021/acs.chemrev.6b00468 ↗
46. Laser-assisted synthesis of colloidal FeWxOy and Fe/FexOy nanoparticles in water and ethanol10.1002/cphc.201701214 ↗
47. Stabilization and functionalization of iron oxide nanoparticles for biomedical applications10.1039/c1nr10173k ↗
48. Davis · 1997 · 83
49. LAPONITE (R)-stabilized iron oxide nanoparticles for in vivo MR imaging of tumors10.1039/C5BM00508F ↗
50. Stability and cytocompatibility of silk fibroin-capped gold nanoparticles10.1016/j.msec.2014.07.024 ↗
51. Colloidal stability, cytotoxicity, and cellular uptake of HfO2 nanoparticles10.1002/jbm.b.34800 ↗
52. Enhancing optical forces on fluorescent Up-Converting nanoparticles by surface charge tailoring10.1002/smll.201402587 ↗
53. Ultrastructural features of gold nanoparticles interaction with HepG2 and HEK293 cells in monolayer and spheroids10.3390/nano10102040 ↗
54. Assessment of cytotoxicity of metal oxide nanoparticles on the basis of fundamental physical-chemical parameters: a robust approach to grouping10.1039/C9EN00785G ↗
55. An overview on nanoparticles used in biomedicine and their cytotoxicity
56. CdTe quantum dots linked to glutathione as a bridge for protein crosslinking10.1016/j.jlumin.2017.03.012 ↗
57. Preparation and characterization of fluorescent CdS quantum dots used for the direct detection of GST fusion proteins regular paper10.5772/53926 ↗
58. (S)TEM structural and compositional nanoanalyses of chemically synthesized glutathione-shelled nanoparticles10.1007/s13204-020-01418-7 ↗
59. Gold nanoparticle surface functionalization: a necessary requirement in the development of novel nanotherapeutics10.2217/nnm.14.219 ↗
60. Glutathione-magnetite nanoparticles: synthesis and physical characterization for application as MRI contrast agent10.1007/s42452-020-3010-y ↗
61. PHASE-EQUILIBRIA in the systems FE2O3-WO3 and FEVO4-WO310.1016/0040-6031(93)80528-I ↗
62. Ieee, liquid-assisted pulsed laser ablation: a novel route to produce multifunctional contrast agents for multimodal imaging diagnosis
63. Powder cell - a program for the representation and manipulation of crystal structures and calculation of the resulting X-ray powder patterns10.1107/S0021889895014920 ↗
64. PARTICLE-SIZE analysis in ferrofluids10.1016/0304-8853(83)90407-9 ↗
65. Double oxide, FE2WO6 .1. Crystalline structure and structural relationship10.1016/0022-4596(74)90002-4 ↗
66. MAGNETIC-STRUCTURE of FE2WO6, a neutron-diffraction study10.1107/S0567739477001648 ↗
67. Original network of zigzag chains in the β polymorph of Fe2WO6: crystal structure and magnetic ordering10.1021/acs.inorgchem.0c01024 ↗
68. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
69. Magnetic nanomaterials as contrast agents for MRI10.3390/ma13112586 ↗
70. Amorphous iron(III) oxide - a review10.1021/jp064992s ↗
71. Sonochemical synthesis of mesoporous iron oxide and accounts of its magnetic and catalytic properties10.1021/jp015532w ↗
72. Surface effects in maghemite nanoparticles10.1016/j.jmmm.2006.09.011 ↗
73. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications10.1016/j.biomaterials.2004.10.012 ↗
74. Magnetite-gold nanohybrids as ideal all-in-one platforms for theranostics10.1038/s41598-018-29618-w ↗
75. Size properties of colloidal nanoparticles produced by nanosecond pulsed laser ablation and studying the effects of liquid medium and laser fluence10.1016/j.apsusc.2014.12.069 ↗
76. Gold nanoparticles: promising and potential nanomaterial
77. Influence of size and surface capping on photoluminescence and cytotoxicity of gold nanoparticles10.1007/s11051-018-4406-0 ↗